Darapladib, a lipoprotein-associated phospholipase A2 inhibitor, in diabetic macular edema: a 3-month placebo-controlled study (Q86885003)
Jump to navigation
Jump to search
scientific article published on 05 March 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Darapladib, a lipoprotein-associated phospholipase A2 inhibitor, in diabetic macular edema: a 3-month placebo-controlled study |
scientific article published on 05 March 2015 |
Statements
Darapladib, a lipoprotein-associated phospholipase A2 inhibitor, in diabetic macular edema: a 3-month placebo-controlled study (English)
Li Ye
Mindy H Magee
Ronald P Danis
Peter Adamson
Megan M McLaughlin
Darapladib DME Study Group